Overview
- Systematically and comprehensively discussing biological, epidemiological and clinical characteristics of HEV
- Introducing the treatment and prevention of HEV
- Providing the experimental methods associated with HEV study
Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 1417)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (17 chapters)
Keywords
About this book
This book systematically and comprehensively discusses the biological, epidemiological, and clinical characteristics of the hepatitis E virus (HEV). It presents current knowledge of HEV and explores experimental methods, treatment, and prevention of HEV. First identified in the 1980s and cloned in 1990, HEV is the causative agent of hepatitis E, which mainly occurs in developing regions, such as Southeast Asia, the Middle East, and Africa, and significantly affects the health of the people in these areas. It is estimated that a third of the world’s population has been infected with HEV, which is transmitted via the fecal-oral route and can infect both humans and animals.
In the second edition, new chapters are added to demonstrate the lifecycle, morphogenesis, and stem cell culture of hepatitis E virus. Although research on hepatitis E virus has made progress recently, there are still some problems that have not been solved. Those problems are discussed in this edition, which would be helpful for researchers to understand the problems on hepatitis E virus that they have faced. Meanwhile, the epidemiology, transmission, genetic evolution, animal models, treatment, and others in the related chapters of the first version were also updated according to the most recent research progress.
The book provides an overview of HEV from benchside to bedside. It is a valuable resource for researchers in the field and those in the pharmaceutical industry developing HEV vaccines, as well as physicians involved in identifying and treating those infected with the virus.
Editors and Affiliations
About the editor
Dr. Youchun Wang used to be Chief Scientist, deputy director of National Institutes for Food and Drug Control. His current position is professor and executive director of Institute of Medical Biology, which locates at Kunming, Yunnan Province and is affiliated to Chinese Academy of Medical Science & Peking Union Medical College. He has also held several positions in academic associations, including as the Former Chairman of the Medical Virology, Vice Chairman of Microbiology and Immunology in the Chinese Medical Association, Former Vice Chairman of the Chinese Laboratory Animal Association, Former Chairman of Beijing Medical Virology, and Chairman of Vaccine committee of the Chinese Pharmacopoeia. He has worked on medical viruses including hepatitis viruses, human immunodeficiency virus, human papillomavirus, and emerging viruses. He has published more than 320 academic papers as the first or corresponding author, more than 150 of which were published in Science Citation Index journals.
Bibliographic Information
Book Title: Hepatitis E Virus
Editors: Youchun Wang
Series Title: Advances in Experimental Medicine and Biology
DOI: https://doi.org/10.1007/978-981-99-1304-6
Publisher: Springer Singapore
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2023
Hardcover ISBN: 978-981-99-1303-9Published: 25 May 2023
Softcover ISBN: 978-981-99-1306-0Due: 25 June 2023
eBook ISBN: 978-981-99-1304-6Published: 24 May 2023
Series ISSN: 0065-2598
Series E-ISSN: 2214-8019
Edition Number: 2
Number of Pages: XII, 256
Number of Illustrations: 1 b/w illustrations
Topics: Virology, Vaccine, Biological Techniques, Infectious Diseases